← Leaderboards
Minnie M Sarwal
Stanford University
$8,971,142
Attributed
$15,261,681
Total exposure
18
Grants
14
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $6.6M · FY2005–25$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$26,492,917 · 19
By mechanism
U19$11,713,529 · 5
R01$10,306,845 · 5
T32$3,091,571 · 1
R21$1,074,000 · 2
P41$206,386 · 4
R56$100,001 · 1
Top collaborators
- Elaine F Reed12 shared
- Peter G Stock10 shared
- David G Camp6 shared
- Jochen Reiser6 shared
- Robert Lowsky4 shared
- Samuel Strober4 shared
- Marina Sirota2 shared
Most similar at Stanford University
Same institution · by research overlap
- Scott L Delp$38,724,527
- William H Robinson$16,848,609
- Paul A Khavari$40,653,927
- Christopher Re$1,860,019
- Christopher Y Park$11,341,558
Others in their field
Top investigators on “Kidney Transplantation”
- Peter Scott Heeger · Case Western Reserve University$86,758,000
- Joren C Madsen · Massachusetts General Hospital$51,129,981
- Dorry Segev · Johns Hopkins University$40,143,271
- Peter G Stock · University Of California San Francisco$37,405,503
- Robert M Merion · University Of Michigan At Ann Arbor$29,566,275
- John C Magee · University Of Michigan At Ann Arbor$28,786,531
Research focus
Kidney TransplantationTransplant RecipientsBaseImmuneVirus DiseasesResourcesKidneyInjuryGraft RejectionUrineInfectionTransplantationProteinsTechnologyImmunologyResearch PersonnelMorbidity - Disease RateChronicCellsClinical PhenotypeBiological MarkersFunctional DisorderSamplingAcute
Grant awards (55)
Computational Drug Repositioning for Antibody Mediated Renal Allograft Rejection$814,298
R01 · FY2025 · AI · contact PI
Filling a Void of Research (FAVOR) Training for Transplant Surgeons$400,331
T32 · FY2025 · AI
Computational Drug Repositioning for Antibody Mediated Renal Allograft Rejection$800,454
R01 · FY2024 · AI · contact PI
Filling a Void of Research (FAVOR) Training for Transplant Surgeons$331,894
T32 · FY2024 · AI
Filling a Void of Research (FAVOR) Training for Transplant Surgeons$315,701
T32 · FY2023 · AI
Filling a Void of Research (FAVOR) Training for Transplant Surgeons$333,694
T32 · FY2022 · AI
Mapping Immune Responses to CMV in Renal Transplant Recipients$1,524,094
U19 · FY2021 · AI
CD40 autoantibody and FSGS recurrence$523,497
R01 · FY2021 · DK · contact PI
Filling a Void of Research (FAVOR) Training for Transplant Surgeons$325,400
T32 · FY2021 · AI
Mapping Immune Responses to CMV in Renal Transplant Recipients - Transplant Supplement$2,132,116
U19 · FY2020 · AI
Mapping Immune Responses to CMV in Renal Transplant Recipients$1,569,278
U19 · FY2020 · AI
Mapping Immune Responses to CMV in Renal Transplant Recipients - Clinical Core$869,489
U19 · FY2020 · AI
CD40 autoantibody and FSGS recurrence$542,692
R01 · FY2020 · DK · contact PI
The KIDCOV Study: Assessment of Kidney Injury and Associated Risk Factors for SARS-CoV-2$459,623
R01 · FY2020 · DK · contact PI
Filling a Void of Research (FAVOR) Training for Transplant Surgeons$323,269
T32 · FY2020 · AI
Mapping Immune Responses to CMV in Renal Transplant Recipients - Mechanistic Assays Core$222,841
U19 · FY2020 · AI
Mapping Immune Responses to CMV in Renal Transplant Recipients - Mechanistic Assays Core (UCSF)$208,861
U19 · FY2020 · AI
Core-003$89,137
U19 · FY2020 · AI
Core-004$77,994
U19 · FY2020 · AI
Core-002$55,710
U19 · FY2020 · AI
Mapping Immune Responses to CMV in Renal Transplant Recipients$1,566,001
U19 · FY2019 · AI
CD40 autoantibody and FSGS recurrence$549,397
R01 · FY2019 · DK · contact PI
Filling a Void of Research (FAVOR) Training for Transplant Surgeons$309,261
T32 · FY2019 · AI
Mapping Immune Responses to CMV in Renal Transplant Recipients$1,569,278
U19 · FY2018 · AI
CD40 autoantibody and FSGS recurrence$556,428
R01 · FY2018 · DK · contact PI
Drug Repositioning in Diabetic Nephropathy$317,000
R21 · FY2018 · TR · contact PI
Filling a Void of Research (FAVOR) Training for Transplant Surgeons$282,065
T32 · FY2018 · AI
Mapping Immune Responses to CMV in Renal Transplant Recipients$1,569,278
U19 · FY2017 · AI
CD40 autoantibody and FSGS recurrence$560,227
R01 · FY2017 · DK · contact PI
Filling a Void of Research (FAVOR) Training for Transplant Surgeons$313,354
T32 · FY2017 · AI
Project 3: Mapping the Evolution of Chronic Transplant Injury in the Context of CMV Infection$259,452
U19 · FY2017 · AI · contact PI
Drug Repositioning in Diabetic Nephropathy$317,000
R21 · FY2016 · TR · contact PI
Filling a Void of Research (FAVOR) Training for Transplant Surgeons$156,602
T32 · FY2016 · AI
Transplant injury biology and monitoring by urine proteomics$100,001
R56 · FY2015 · DK · contact PI
Urinary Proteome Monitoring for Transplant Injury$339,730
R01 · FY2013 · DK · contact PI
Urinary Proteome Monitoring for Transplant Injury$162,525
R01 · FY2013 · DK · contact PI
Urinary Proteome Monitoring for Transplant Injury$558,405
R01 · FY2012 · DK · contact PI
Gene and Cytokine Expression in Tolerance and GVHD$392,040
R01 · FY2012 · AI
Urinary Proteome Monitoring for Transplant Injury$393,556
R01 · FY2011 · DK · contact PI
Gene and Cytokine Expression in Tolerance and GVHD$392,040
R01 · FY2011 · AI
Urinary Proteome Monitoring for Transplant Injury$179,734
R01 · FY2011 · DK · contact PI
DISCOVERY OF NOVEL URINARY PROTEOMIC BIOMARKERS IN KIDNEY TRANSPLANTATION$28,669
P41 · FY2011 · RR · contact PI
Urinary Proteome Monitoring for Transplant Injury$719,327
R01 · FY2010 · DK · contact PI
Gene and Cytokine Expression in Tolerance and GVHD$396,000
R01 · FY2010 · AI · contact PI
Novel Urinary Proteomic Biomarkers for Acute Renal Transplant Rejection$200,000
R21 · FY2010 · AI · contact PI
DISCOVERY OF NOVEL URINARY PROTEOMIC BIOMARKERS IN KIDNEY TRANSPLANTATION$32,124
P41 · FY2010 · RR · contact PI
Gene and Cytokine Expression in Tolerance and GVHD$400,000
R01 · FY2009 · AI
Novel Urinary Proteomic Biomarkers for Acute Renal Transplant Rejection$240,000
R21 · FY2009 · AI · contact PI
DISCOVERY OF NOVEL URINARY PROTEOMIC BIOMARKERS IN KIDNEY TRANSPLANTATION$97,568
P41 · FY2009 · RR · contact PI
DISCOVERY OF NOVEL URINARY PROTEOMIC BIOMARKERS IN KIDNEY TRANSPLANTATION$48,025
P41 · FY2008 · RR · contact PI
Defining Biomarkers in Pediatric Renal Transplantation$379,272
R01 · FY2007 · AI · contact PI
TACROLIMUS WITH STEROIDS AND STANDARD DACLIZUMAB VERSUS STEROID-FREE TACROLIMUS$585
M01 · FY2007 · RR · contact PI
Defining Biomarkers in Pediatric Renal Transplantation$390,600
R01 · FY2006 · AI · contact PI
Defining Biomarkers in Pediatric Renal Transplantation$400,000
R01 · FY2005 · AI
Defining Biomarkers in Pediatric Renal Transplantation$397,000
R01 · FY2004 · AI